• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS HCG + BETA TEST SYSTEM; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS HCG + BETA TEST SYSTEM; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN Back to Search Results
Catalog Number 03271749160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/27/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
The customer obtained questionable high elecsys hcg + beta test system (hcg+b) results using the analytical e module (serial (b)(4)) for two female patients who were not pregnant.Of the data provided, the results for patient a were discrepant.The customer initially believed the results to be true positives due to possible tumors secreting hcg+b.The customer states that the hcg+b results "reduced over time" after treatment with methotrexate.All results are in units of miu/ml, and all were released outside the laboratory.No data flags or alarms occurred.Patient a: the initial sample was drawn (b)(6) 2017 and analyzed (b)(6) 2017.The initial result was 36; repeat results were 35 and 35.A second sample was drawn (b)(6) 2017 and analyzed (b)(6) 2017.The initial result was 37; repeat results were 38 and 38.The patient and physician had performed "spot" (random) urine pregnancy tests that were also positive.On an unspecified date, the patient underwent an ultrasound which was negative, and she was treated with methotrexate.The patient was not adversely affected.The customer requested investigational confirmation testing for the samples.No samples from patient a were received, and the clinician stated he did not require additional testing.A specific root cause could not be identified.Additional information for further investigation was requested but was not provided.
 
Manufacturer Narrative
Medical assessment of the event stated there is a lag time in the detect-ability of pregnancy between an hcg + b test and an ultrasound result.It is likely that the patient was in the early stages of pregnancy resulting in a negative ultrasound result.A product problem was not identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS HCG + BETA TEST SYSTEM
Type of Device
SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6785440
MDR Text Key83278621
Report Number1823260-2017-01673
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K003178
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 10/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03271749160
Device Lot Number179825
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age28 YR
-
-